-
Product Insights
New5-Hydroxytryptamine Receptor 1 – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 1 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Cardiovascular, and Oncology which include indications of Schizophrenia, Migraine, Inflammation, Psoriasis, Pulmonary Arterial Hypertension, Stroke, Breast Cancer, and Melanoma. It also reviews key players involved in 5-Hydroxytryptamine Receptor...
-
Product Insights
NewCarbonic Anhydrase – Drugs In Development, 2024
The Carbonic Anhydrase pipeline drugs market research report outlays comprehensive information on the Carbonic Anhydrase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Ophthalmology, and Metabolic Disorders which include indications of Oncology, Glioblastoma Multiforme (GBM), Epilepsy, Migraine, Ocular Hypertension, Open-Angle Glaucoma, and Obesity. It also reviews key players involved in Carbonic Anhydrase targeted...
-
Product Insights
NewF2R Receptor – Drugs In Development, 2024
The F2R Receptor pipeline drugs market research report outlays comprehensive information on the F2R Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Cardiovascular, Central Nervous System, and Gastrointestinal which include indications of Asthma, Unspecified Respiratory Disorders, Thrombosis, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Migraine, Unspecified Neurologic Disorders, Inflammatory Bowel Disease, and Metabolic Dysfunction-Associated Steatohepatitis...
-
Product Insights
New5-Hydroxytryptamine Receptor 1B – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 1B pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Migraine, Bipolar Disorder (Manic Depression), and Pulmonary Arterial Hypertension. It also reviews key players involved in 5-Hydroxytryptamine Receptor 1B targeted therapeutics development with...
-
Product Insights
NewProteinase Activated Receptor 2 – Drugs In Development, 2024
The Proteinase Activated Receptor 2 pipeline drugs market research report outlays comprehensive information on the Proteinase Activated Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Gastrointestinal, and Immunology which include indications of Asthma, Unspecified Respiratory Disorders, Migraine, Unspecified Neurologic Disorders, Inflammatory Bowel Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Psoriasis, and Unspecified Immunological...
-
Product Insights
NewMAP Kinase Interacting Serine/Threonine Protein Kinase 1 – Drugs In Development, 2024
The MAP Kinase Interacting Serine/Threonine Protein Kinase 1 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Interacting Serine/Threonine Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Central Nervous System which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Migraine, and Neuropathic Pain (Neuralgia). It also reviews key...
-
Product Insights
NewMitogen Activated Protein Kinase Interacting Kinase – Drugs In Development, 2024
The Mitogen Activated Protein Kinase Interacting Kinase pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase Interacting Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology. It also...
-
Product Insights
NewMAP Kinase Interacting Serine/Threonine Protein Kinase 2 – Drugs In Development, 2024
The MAP Kinase Interacting Serine/Threonine Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the MAP Kinase Interacting Serine/Threonine Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Dermatology which include indications of Triple-Negative Breast Cancer (TNBC), Non-Small Cell Lung Cancer, Migraine, Neuropathic Pain (Neuralgia), and Dermatology....
-
Product Insights
NewInsulin Like Growth Factor 1 Receptor – Drugs In Development, 2024
The Insulin Like Growth Factor 1 Receptor pipeline drugs market research report outlays comprehensive information on the Insulin Like Growth Factor 1 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, Central Nervous System, and Respiratory which include indications of Non-Small Cell Lung Cancer, Atypical Teratoid Rhabdoid Tumor, Graves' Ophthalmopathy, Retinal Vein Occlusion, Epilepsy, Migraine,...
-
Product Insights
New5-Hydroxytryptamine Receptor 1D – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 1D pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1D targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System which include indications of Migraine, and Cluster Headache Syndrome (Cluster Headache). It also reviews key players involved in 5-Hydroxytryptamine Receptor 1D targeted therapeutics development with respective active and dormant...